ICM and SIRIC Montpellier Cancer have reached a milestone with the official launch of Project AMBER, in partnership with TAE Life Sciences. This initiative aims to establish France’s first Boron Neutron Capture Therapy (BNCT) unit in Montpellier, transforming the treatment landscape for poor-prognosis cancers such as certain brain tumors and pancreatic cancer.
The SIRIC Montpellier Cancer IRP-2 PANACEA Research Program supports the FREEDOME study, coordinated by neuro-oncologist Dr. Amélie Darlix and neuropsychologist Dr. Estelle Guerdoux from the Montpellier Cancer Institute.
Initiatives like the PINKCC challenge are really important to spur innovation around important challenges and establish strong, open benchmarks for the scientific community. But, even more importantly, they show a new generation of AI developers that AI can be used to address challenges that really make a difference to people’s lives. Dr Christopher Bridge –
SIRIC Montpellier Cancer and the IRCM, are delighted to announce the installation of the Hyperion XTi
